VPI-251

N/A

Report date: 2025/01/26 17:27:21

Base Information

Drug NameVPI-251
Drug Alias NameRSV-VaultVPI-251
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesVault Pharma Inc
Inactive CompaniesN/A
Active IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A